7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-05-31 2013-02-28 2012-11-30 2012-08-31 2012-05-31 2012-02-29 2011-11-30 2011-08-31 2011-02-28 2010-11-30 2010-08-31 2010-02-28 2009-11-30 2009-08-31 2009-02-28 2008-11-30 2008-08-31 2008-02-29 2007-11-30 2007-08-31 2007-02-28 2006-11-30 2006-08-31 2005-08-31 2005-02-28 
      
                                                                            
      cash flows from operating activities:
                                                                            
      net earnings including noncontrolling interests
    424,100,000 419,700,000 250,000,000 165,700,000 130,700,000 -150,900,000 56,500,000 368,000,000 3,100,000 379,100,000 459,000,000 528,500,000 856,200,000 1,043,800,000 1,185,700,000 376,500,000 438,800,000 158,200,000 828,300,000 -4,600,000 45,900,000 -204,000,000 -950,400,000 -40,000,000 -230,300,000 129,900,000 112,000,000 249,700,000 68,100,000 40,100,000 -429,800,000 229,600,000 97,100,000 -1,100,000 14,600,000 40,700,000 -11,000,000 256,900,000 155,500,000 160,700,000 391,000,000 294,600,000 361,600,000 202,900,000 248,200,000 217,700,000 125,800,000 485,400,000 345,400,000 630,300,000 430,700,000  271,900,000 625,600,000 526,400,000                  
      adjustments to reconcile net earnings including noncontrolling interests to net cash from operating activities:
                                                                            
      depreciation, depletion and amortization
    277,000,000 261,700,000 243,000,000 282,100,000 237,900,000 264,400,000 241,100,000 257,700,000 238,700,000 244,200,000 220,000,000 233,000,000 229,200,000 245,000,000 226,700,000 186,100,000 203,500,000 209,100,000 208,500,000 205,900,000 215,400,000 217,800,000 233,100,000 210,800,000 220,700,000 218,100,000 235,100,000 214,500,000 216,800,000 217,500,000 172,000,000 168,800,000 165,900,000 158,800,000 165,500,000 172,700,000 189,300,000 183,700,000 185,000,000 180,900,000 191,100,000 182,800,000 192,700,000 189,500,000 194,400,000 174,300,000 166,100,000 167,800,000 152,200,000 147,400,000 137,400,000 139,700,000 127,900,000 120,200,000 120,300,000 114,100,000 105,700,000 104,700,000 101,600,000 138,900,000 92,100,000 90,400,000 89,400,000 87,700,000       74,300,000 72,400,000 
      deferred and other income taxes
    31,100,000 35,600,000 -11,000,000 -179,100,000 -3,600,000 115,100,000 -75,300,000 -228,700,000 -36,200,000 4,900,000 -1,200,000 11,600,000 35,500,000 167,100,000 130,200,000 109,000,000 75,900,000 -37,000,000 -533,400,000 -26,800,000 -16,500,000 -107,300,000 -258,400,000 26,700,000 -34,900,000 5,300,000 -89,500,000 83,300,000 -32,400,000 -63,200,000 558,500,000 19,900,000 -25,100,000 59,100,000 -54,700,000 -58,100,000 -16,400,000 -53,400,000                                   
      equity in net (earnings) of nonconsolidated companies, net of dividends
    -800,000 -600,000 -400,000 -6,500,000 -4,500,000 -22,200,000 -22,500,000 3,300,000 -15,900,000 -12,900,000 -6,300,000                                                              
      accretion expense for asset retirement obligations
    32,700,000 32,600,000 32,200,000 30,300,000 26,800,000 26,900,000 27,200,000 26,100,000 24,000,000 23,200,000 22,800,000 22,400,000 19,600,000 20,000,000 19,600,000 17,700,000 18,000,000 17,100,000 17,300,000 16,700,000 16,700,000 17,300,000 18,100,000 15,600,000 13,400,000 15,300,000 10,800,000 12,700,000 12,400,000 12,100,000 6,100,000 6,500,000 6,600,000 6,500,000 10,400,000 10,200,000 10,400,000 9,400,000 8,700,000 8,200,000 7,700,000 7,800,000 12,300,000 8,600,000 10,700,000 10,500,000 9,900,000 7,300,000 9,600,000 8,300,000 8,100,000 11,200,000 7,100,000 7,000,000 7,100,000 9,700,000 7,200,000 7,100,000 8,200,000 7,100,000 7,900,000 12,500,000 5,700,000 8,800,000       13,400,000  
      share-based compensation expense
    6,500,000 8,400,000 9,300,000 5,100,000 5,500,000 11,900,000 9,300,000 6,000,000 6,000,000 8,600,000 12,400,000 5,900,000 6,500,000 -900,000 16,400,000 5,100,000 4,300,000 14,900,000 12,600,000 7,100,000 8,200,000 -10,100,000 2,900,000 2,900,000 6,800,000 15,300,000 1,800,000 3,000,000 7,000,000 15,700,000 3,500,000 3,600,000 5,000,000 15,900,000 4,000,000 4,200,000 5,400,000 16,900,000 5,400,000 2,000,000 29,300,000 4,600,000 5,100,000 5,700,000 8,600,000 34,900,000 14,100,000 2,700,000 2,900,000 4,800,000 17,800,000 3,300,000 3,100,000 3,200,000 13,800,000                  
      unrealized (gain) loss on equity securities
    -308,000,000 -216,300,000 116,600,000                                                                      
      unrealized (gain) loss on derivatives
    27,200,000 -54,600,000 -57,700,000           32,400,000 -98,800,000                  -5,000,000 1,800,000  9,800,000 -37,100,000 -54,200,000  12,700,000 -31,500,000 45,400,000   -37,500,000 7,900,000             -19,900,000     117,200,000         
      foreign currency adjustments
    65,100,000 -192,000,000 -159,000,000 345,200,000 -232,000,000 254,600,000 94,900,000 -57,800,000 118,100,000 -103,000,000 -51,300,000 -26,800,000 35,200,000 242,600,000 -318,900,000 97,300,000 -150,900,000 34,500,000 -131,800,000 -61,400,000                                                     
      impairment of assets held for sale
                                                                            
      amortization of debt financing fees
    10,500,000                                                                        
      other
    21,100,000 68,300,000 11,400,000 -3,600,000 7,600,000 48,100,000 19,700,000 -44,500,000 30,800,000 24,700,000 26,500,000 -30,700,000 19,800,000 38,100,000 11,800,000 9,100,000 -17,900,000 800,000 -19,500,000 -9,600,000 -700,000 10,700,000 1,900,000 -6,000,000 -4,400,000 5,600,000 -2,900,000 14,200,000 -1,300,000 8,300,000 2,500,000 -3,700,000 9,000,000 17,400,000 -5,400,000 -400,000 6,600,000 26,800,000 5,300,000 11,200,000 4,100,000 4,500,000 -2,500,000 4,900,000 4,000,000 -3,100,000 -8,100,000 11,100,000 -4,700,000 14,100,000 600,000 9,700,000 -1,400,000 -500,000 15,300,000 -2,400,000 1,700,000 700,000 2,500,000 -700,000 7,700,000 5,600,000 -1,000,000 5,700,000 100,000 800,000 700,000 -200,000 100,000 -1,700,000  
      changes in assets and liabilities:
                                                                            
      receivables
    57,300,000 -45,000,000 59,600,000 -136,200,000 273,600,000 -109,000,000 30,800,000 193,700,000 -203,700,000 225,600,000 310,700,000 213,900,000 292,200,000 -808,300,000 87,000,000 -175,300,000 -44,900,000 -1,500,000 -91,300,000 -105,100,000 28,000,000 14,800,000 1,400,000 -134,700,000 108,900,000 59,000,000 37,500,000 -163,800,000 69,700,000 62,500,000 -84,400,000 -58,200,000 5,700,000 45,700,000 -118,600,000 -134,900,000 239,900,000 17,100,000 -1,600,000 -104,400,000 37,300,000 8,000,000 -162,500,000 6,100,000 14,800,000 -84,900,000 131,700,000 -155,200,000 -77,700,000 -75,300,000 11,500,000 -120,900,000 253,200,000 -144,400,000 130,600,000 -137,600,000 -87,600,000 41,300,000 -32,300,000 -96,500,000 111,500,000 269,400,000 577,600,000 -521,000,000       -16,400,000 -17,200,000 
      inventories
    -200,800,000 -215,700,000 -162,400,000 241,700,000 -347,500,000 -54,900,000 -114,900,000 -46,200,000 636,600,000 229,800,000 241,200,000 292,900,000 -224,100,000 -536,800,000 -281,600,000 -172,700,000 -221,300,000 -180,700,000 -1,000,000 263,000,000 -46,200,000 -24,400,000 227,200,000 314,500,000 -109,100,000 -304,500,000 -299,300,000 171,500,000 -222,000,000 -147,600,000 98,900,000 51,100,000 -172,400,000 -133,300,000 104,500,000 195,100,000 -70,900,000 34,300,000 -10,900,000 -73,400,000 -77,900,000 108,500,000 -168,000,000 74,500,000 -8,900,000 -27,300,000 -2,500,000 19,200,000 -62,200,000 -26,100,000 -246,400,000 72,700,000 -123,400,000 193,000,000 -135,800,000 -314,900,000 227,700,000 -42,300,000 15,300,000 77,800,000 78,900,000 176,200,000 -1,900,000 -590,200,000       -21,400,000 -116,700,000 
      other current and noncurrent assets
    3,700,000 -31,200,000 55,100,000  -117,500,000 -117,200,000 55,000,000  -71,500,000 -81,500,000 -194,300,000  28,400,000 -139,000,000 -88,100,000 -33,200,000 -67,100,000 14,000,000  -14,700,000 162,900,000 -107,900,000  3,500,000 -700,000 -66,000,000  -25,000,000 86,600,000 -137,500,000  28,600,000 -3,600,000 -67,700,000  23,000,000 39,300,000 -22,000,000  -82,400,000 -114,600,000 -36,500,000  50,300,000 15,000,000 151,400,000 -167,800,000  106,100,000 -85,400,000 72,800,000  -191,300,000 -101,100,000 1,500,000 -37,900,000 15,500,000 61,900,000    -19,100,000           
      accounts payable and accrued liabilities
    -287,800,000 450,600,000 -331,900,000 -161,400,000 219,300,000 516,200,000 -477,700,000 -128,600,000 -194,800,000 109,900,000 -841,600,000 -324,400,000 -528,700,000 1,369,800,000 -296,900,000 -54,200,000 659,400,000 64,600,000 -77,100,000 19,400,000 58,300,000 332,700,000 -184,700,000 91,500,000 154,500,000 -186,700,000 -124,500,000 -50,600,000 592,000,000 -74,900,000 -27,300,000 -257,600,000 180,600,000 38,600,000 -81,200,000 -173,800,000 148,800,000 -137,700,000                                   
      other noncurrent liabilities
    -3,400,000 64,900,000 -11,900,000 -13,600,000 155,300,000 35,300,000 43,300,000 22,300,000 28,800,000 60,500,000 -3,300,000 11,800,000 103,600,000 -56,100,000 -59,400,000 31,800,000 -13,400,000 20,600,000 -2,800,000 53,100,000 61,000,000 -21,600,000 9,500,000 -1,900,000 -6,000,000 -22,300,000 -1,400,000 18,400,000 15,900,000 8,200,000 10,200,000 3,900,000 -7,400,000 12,700,000 25,100,000 1,000,000 19,100,000 700,000 12,100,000 -14,300,000 21,700,000 -17,700,000 -121,800,000 -17,100,000 60,900,000 -29,900,000 -83,200,000 -1,900,000 -37,700,000 -123,200,000 2,000,000 63,100,000 74,300,000 -55,900,000 -15,500,000 -6,700,000 -47,800,000 300,000 -32,700,000 11,100,000 9,600,000 -87,200,000 23,100,000 -80,400,000         
      net cash from operating activities
    228,500,000 609,500,000 42,900,000 219,300,000 312,900,000 847,000,000 -80,000,000 538,100,000 647,400,000 1,072,700,000 149,000,000 955,700,000 888,800,000 1,585,100,000 506,200,000 422,700,000 1,015,100,000 318,800,000 238,400,000 340,600,000 813,700,000 189,900,000 277,600,000 486,000,000 507,300,000 -175,500,000 150,000,000 523,800,000 807,000,000 -71,000,000 411,200,000 135,500,000 242,800,000 146,000,000 321,200,000 95,800,000 583,200,000 265,900,000 286,900,000 282,100,000 583,100,000 655,500,000 381,800,000 488,600,000 796,300,000 627,000,000 -45,000,000 854,700,000 371,100,000 322,400,000 339,300,000 1,229,300,000 404,500,000 517,700,000 554,300,000 365,900,000 531,700,000 556,200,000 476,700,000 174,800,000 172,400,000 -11,200,000 386,500,000 561,500,000 528,000,000 542,500,000 438,400,000 147,500,000 142,200,000 150,600,000 81,200,000 -83,600,000 
      cash flows from investing activities:
                                                                            
      capital expenditures
    -364,400,000 -304,600,000 -340,800,000 -294,100,000 -240,800,000 -333,900,000 -383,000,000 -358,900,000 -411,700,000 -310,300,000 -321,500,000 -340,500,000 -353,700,000 -262,600,000 -290,500,000 -340,000,000 -297,200,000 -288,600,000 -384,800,000 -265,100,000 -257,200,000 -263,500,000 -341,100,000 -322,300,000 -294,900,000 -313,900,000 -289,100,000 -241,000,000 -201,100,000 -223,300,000 -230,200,000 -197,600,000 -168,500,000 -223,800,000 -209,400,000 -196,400,000 -201,700,000 -235,600,000 -298,100,000 -245,300,000 -227,400,000 -229,500,000 -251,800,000 -188,400,000 -214,000,000 -274,900,000 -332,500,000 -347,900,000 -397,800,000 -393,500,000 -449,100,000 -449,000,000 -411,800,000 -387,100,000 -391,400,000 -311,600,000 -291,000,000 -294,700,000 -208,800,000 -190,600,000 -236,200,000 -196,700,000 -223,200,000 -186,900,000 -86,600,000 -79,100,000 -82,100,000 -61,900,000 -29,400,000 -85,200,000 -90,700,000 -65,700,000 
      free cash flows
    -135,900,000 304,900,000 -297,900,000 -74,800,000 72,100,000 513,100,000 -463,000,000 179,200,000 235,700,000 762,400,000 -172,500,000 615,200,000 535,100,000 1,322,500,000 215,700,000 82,700,000 717,900,000 30,200,000 -146,400,000 75,500,000 556,500,000 -73,600,000 -63,500,000 163,700,000 212,400,000 -489,400,000 -139,100,000 282,800,000 605,900,000 -294,300,000 181,000,000 -62,100,000 74,300,000 -77,800,000 111,800,000 -100,600,000 381,500,000 30,300,000 -11,200,000 36,800,000 355,700,000 426,000,000 130,000,000 300,200,000 582,300,000 352,100,000 -377,500,000 506,800,000 -26,700,000 -71,100,000 -109,800,000 780,300,000 -7,300,000 130,600,000 162,900,000 54,300,000 240,700,000 261,500,000 267,900,000 -15,800,000 -63,800,000 -207,900,000 163,300,000 374,600,000 441,400,000 463,400,000 356,300,000 85,600,000 112,800,000 65,400,000 -9,500,000 -149,300,000 
      purchases of available-for-sale securities - restricted
    -100,600,000 -395,100,000 -102,500,000 -367,700,000 -430,900,000 -106,400,000 -624,700,000 -201,100,000 -227,900,000 -207,200,000 -604,600,000 -302,900,000 -33,700,000 -368,100,000 -57,800,000 -122,800,000 -76,800,000 -123,700,000 -119,500,000 -150,700,000 -138,500,000 -210,000,000 -73,300,000 -250,100,000 -47,300,000 -186,900,000 -48,400,000 -228,500,000 -71,900,000 -185,700,000 -130,000,000 -280,000,000 -530,200,000 -736,100,000 -925,000,000                                      
      proceeds from sale of available-for-sale securities - restricted
    100,500,000 380,300,000 97,100,000 382,000,000 421,100,000 78,200,000 619,800,000 197,400,000 214,900,000 205,600,000 591,200,000 298,400,000 29,400,000 363,300,000 51,900,000 117,100,000 75,300,000 110,800,000 117,700,000 148,500,000 137,200,000 203,800,000 65,000,000 246,400,000 39,500,000 182,300,000 48,300,000 221,100,000 65,400,000 184,000,000 124,400,000 277,600,000 521,800,000 734,300,000 890,400,000                                      
      net cash from investing activities
    -362,900,000 -318,500,000 -340,800,000 -276,500,000 -247,700,000 -349,000,000 -387,800,000 -362,200,000 -422,100,000 -311,500,000 -221,400,000 -343,100,000 -354,600,000 -264,700,000 -297,200,000 -351,000,000 -271,100,000 -308,500,000 -394,800,000 -267,100,000 -257,900,000 -269,700,000 -346,800,000 -326,500,000 -358,700,000 -328,900,000 -283,800,000 -243,800,000 -196,700,000 -1,220,400,000  -220,700,000 -177,000,000 -245,600,000  -382,000,000 -356,500,000 -273,900,000  -822,600,000 -343,400,000 -182,900,000  -158,100,000 -360,300,000 -1,634,300,000 -465,700,000  -390,100,000 -396,100,000 -443,800,000  -404,700,000 -384,600,000 -392,500,000 -271,600,000 740,000,000 -681,600,000 -204,700,000 -154,600,000 -236,100,000 -192,900,000 491,400,000 -187,800,000 -56,900,000 -79,100,000 -73,700,000 -74,200,000 -29,600,000 -85,100,000 -80,100,000 -66,200,000 
      cash flows from financing activities:
                                                                            
      payments of short-term debt
    -4,350,600,000 -3,431,300,000 -3,618,700,000 -4,358,300,000 -4,253,100,000 -3,572,000,000 -4,596,200,000 -3,070,100,000 -1,466,300,000 -2,167,700,000 -3,127,900,000 -1,602,600,000 -39,300,000 524,000,000 -643,300,000   -209,800,000 -511,200,000 -688,900,000 -132,600,000 -112,500,000 -119,000,000 -269,000,000 -53,700,000 -24,300,000 -31,200,000   -78,200,000 -258,000,000 -250,700,000 -14,500,000 -87,600,000 -160,000,000 -99,600,000 -74,100,000 -70,200,000 -152,200,000 -112,100,000 -32,700,000 -1,000,000 -95,500,000 -65,500,000 -58,400,000 -42,900,000 -132,400,000 -60,800,000 -36,400,000 -33,500,000 -59,100,000 -17,500,000 -46,900,000 -25,300,000 -68,600,000 -134,000,000 -90,900,000 -134,000,000 -57,900,000 -63,200,000 -116,700,000 -51,800,000 -141,500,000 -134,200,000 -185,400,000 -91,600,000 -100,500,000 -181,000,000 -256,100,000   
      proceeds from issuance of short-term debt
    4,564,500,000 3,237,000,000 3,804,500,000 4,460,000,000 4,423,400,000 3,249,000,000 4,900,400,000 3,170,000,000 1,537,600,000 1,943,000,000 3,356,500,000 1,827,700,000 22,500,000 -684,100,000 814,400,000 10,000,000 15,000,000 3,800,000 122,300,000 289,600,000 1,105,400,000 69,700,000 116,800,000 198,500,000 206,000,000 9,900,000 38,000,000 41,900,000 65,300,000 23,300,000 264,700,000 200,400,000 143,000,000 35,100,000 159,200,000 112,500,000 90,200,000 77,200,000 144,000,000 129,100,000 29,400,000 14,200,000 83,200,000 36,900,000 65,900,000 57,200,000 139,900,000 100,800,000 39,900,000 8,500,000 20,200,000 70,800,000 61,600,000 15,300,000 88,300,000 112,600,000 83,700,000 90,700,000 90,800,000 77,700,000 95,100,000 53,400,000 118,600,000 258,100,000 136,800,000 106,100,000 84,800,000 129,000,000 231,600,000   
      payments of inventory financing arrangement
    -602,900,000 -602,200,000 -199,500,000  -703,900,000 -500,900,000 -200,300,000     -200,600,000                                                            
      proceeds from inventory financing arrangement
    501,200,000 603,000,000 401,600,000 399,400,000 401,800,000 502,100,000 701,200,000 200,600,000 400,800,000 401,100,000                                                            
      payments of structured accounts payable arrangements
    -230,800,000 -263,700,000 -204,900,000 -232,700,000 -104,800,000 -191,400,000 -226,100,000 -422,300,000 -238,700,000 -390,700,000 -381,200,000 -332,500,000 -373,400,000 -308,200,000 -462,500,000 -333,000,000 -181,700,000 -161,000,000 -308,200,000 -146,400,000 -288,700,000 -412,900,000 -214,600,000 -164,400,000 -278,400,000 -319,700,000 -179,700,000 -144,200,000 -202,500,000 -235,700,000 -179,700,000 -83,000,000 -120,500,000 -35,300,000 -188,500,000 -109,100,000 -270,300,000 -224,300,000 -84,300,000                                  
      proceeds from structured accounts payable arrangements
    225,600,000 275,800,000 182,100,000 227,100,000 234,400,000 184,900,000 90,900,000 214,200,000 238,600,000 425,600,000 169,800,000 439,900,000 224,200,000 232,800,000 563,600,000 235,200,000 212,800,000 314,700,000 316,400,000 355,700,000 193,700,000 171,600,000 259,000,000 419,800,000 235,900,000 209,500,000 243,900,000 259,200,000 157,200,000 173,800,000 193,000,000 226,400,000 140,100,000 107,300,000 92,300,000 135,300,000 110,200,000 95,800,000 305,400,000                                  
      proceeds from issuance of long-term debt
                             100,000   1,249,900,000 200,000 1,300,000     -1,200,000 2,100,000   4,800,000 803,100,000 3,900,000 200,000 2,700,000 100,000 600,000 100,000 1,100,000 -200,000 1,500,000 741,400,000 5,300,000 16,900,000   600,000 100,000    1,997,700,000 100,000 200,000  399,100,000 
      collections of transferred receivables
    113,200,000 -1,800,000 105,800,000 95,400,000 103,500,000 125,000,000 101,600,000 290,900,000 569,500,000 608,200,000 1,068,500,000 600,100,000 236,600,000 446,900,000 121,600,000                                                         
      payments of transferred receivables
    -116,400,000 5,000,000 -105,800,000 -96,900,000 -102,100,000 -125,900,000 -100,600,000 -381,100,000 -480,500,000 -607,000,000 -1,069,700,000 -598,900,000 -389,000,000 -375,600,000 -102,200,000                                                         
      payments of long-term debt
    -14,900,000 -27,900,000 -11,700,000 -12,000,000 -12,700,000 -27,100,000 -15,400,000 -950,500,000 -15,700,000 -14,100,000 -15,000,000 -565,800,000 -15,900,000 -14,500,000 -14,100,000 -466,000,000 -14,200,000 -114,500,000 -16,000,000 -19,500,000 -17,200,000 -14,200,000 -15,400,000 -11,500,000 -11,300,000 -10,100,000 -80,500,000 -408,500,000 -107,000,000 -206,900,000 -96,000,000 -2,800,000 -1,800,000 -1,600,000 -726,100,000 -41,200,000 -600,000 -1,200,000 -1,200,000 -56,000,000 -1,800,000 -600,000 -600,000 -500,000 -700,000 -300,000 -700,000 -600,000 -500,000 -200,000 -200,000 -100,000 -512,500,000 -28,400,000 -1,800,000 -459,600,000 -3,800,000 -3,700,000 -3,500,000 -17,700,000 -17,400,000 -3,800,000 -67,300,000 -33,800,000 -158,800,000 -454,400,000 -183,100,000 -1,760,700,000 -5,400,000 -6,100,000  -267,200,000 
      repurchases of stock
       -25,000,000 -50,000,000 -52,000,000 -108,400,000 -150,000,000 -150,000,000 -456,000,000 -64,000,000 -601,800,000 -577,300,000 -422,100,000        -32,800,000            -75,000,000  -74,900,000 -500,100,000 -134,400,000  -375,000,000 -454,800,000 -1,677,900,000                           
      cash dividends paid
    -69,500,000 -70,100,000 -70,900,000 -66,500,000 -66,800,000 -67,700,000 -69,700,000 -65,100,000 -66,400,000 -67,700,000 -152,400,000 -34,400,000 -68,800,000 -53,900,000 -40,600,000 -28,400,000 -28,600,000 -18,900,000 -19,000,000 -18,900,000 -19,000,000 -18,900,000 -19,000,000 -19,300,000 -19,300,000 -9,600,000 -9,600,000 -9,700,000 -9,600,000 -9,600,000 -8,800,000 -52,700,000 -52,700,000 -96,400,000 -96,300,000 -96,400,000 -96,200,000 -96,200,000 -96,900,000 -98,300,000 -98,100,000 -91,400,000 -93,900,000 -93,800,000 -95,100,000 -99,700,000      -53,400,000 -21,400,000 -22,300,000 -22,400,000 -22,400,000 -22,300,000 -22,300,000 -600,900,000 -22,600,000 -22,200,000 -22,200,000 -22,200,000 -22,200,000       -2,600,000  
      dividends paid to non-controlling interest
    -6,700,000   -14,300,000 -5,800,000 -3,600,000 -8,200,000                                                                  
      net cash from financing activities
    3,800,000 -285,200,000 272,000,000 36,700,000 -137,900,000 -488,600,000 457,900,000 -410,700,000 -254,200,000 -606,600,000 -209,000,000 -573,000,000 -649,500,000 -1,331,200,000 -125,000,000 -618,300,000 -82,100,000 121,700,000 -232,900,000 -218,500,000 -530,700,000 698,300,000 -65,900,000 105,200,000 -143,800,000 22,300,000 -45,200,000 -296,400,000 -169,900,000 -213,300,000 1,089,600,000 94,300,000 -85,300,000 102,200,000  -111,600,000 -242,500,000 -280,000,000 135,400,000 -224,600,000 -577,200,000 -227,000,000 -318,500,000 323,300,000 -574,500,000 -1,770,300,000 -89,500,000  -65,600,000 -103,600,000 -131,800,000  -479,900,000 -460,400,000 -28,800,000 -452,400,000 -30,200,000 -33,000,000 -639,000,000 -5,700,000 -27,500,000 -47,700,000 -83,100,000 -76,500,000 17,100,000 -485,700,000 -150,300,000 103,600,000 -36,900,000 -28,900,000 -37,300,000 138,400,000 
      effect of exchange rate changes on cash
    5,500,000 17,900,000 -400,000 -6,600,000 54,500,000 -6,200,000 -3,800,000 -6,200,000 -10,100,000 9,200,000 4,300,000 -8,000,000 -19,600,000 -33,200,000 31,100,000 -32,100,000 69,200,000 -20,100,000 38,600,000 -1,500,000 -15,400,000 -68,900,000 8,900,000 -24,200,000 10,800,000 13,500,000 -900,000 -11,200,000 -65,000,000 13,400,000 -8,300,000 18,300,000 1,500,000 3,000,000 -10,000,000 -8,000,000 17,400,000 69,400,000 -31,400,000 -159,900,000 30,000,000 -102,800,000 -72,900,000 -50,200,000 14,800,000 -24,800,000 23,300,000 -23,700,000 -13,400,000 3,200,000 20,100,000 -82,600,000 54,400,000 -83,100,000 -1,400,000 50,800,000 55,200,000 -1,900,000 10,700,000 34,900,000 -13,300,000 -30,800,000 -172,900,000 -68,200,000 3,800,000 25,300,000 4,200,000   4,900,000 -7,500,000  
      net change in cash, cash equivalents and restricted cash
    -125,100,000 23,700,000 -26,300,000 -27,100,000 -18,200,000 3,200,000 -13,700,000 -241,000,000 -39,000,000 163,800,000 -277,100,000 31,600,000 -134,900,000 -44,000,000 115,100,000 -578,700,000 731,100,000 111,900,000 -350,700,000 -146,500,000 9,700,000 549,600,000 -126,200,000 240,500,000 15,600,000 -468,600,000 -179,900,000 -27,600,000 375,400,000 -1,491,300,000  27,400,000 -18,000,000 5,600,000                                       
      cash, cash equivalents and restricted cash - december 31
    305,000,000  360,800,000  754,100,000  786,300,000 594,400,000                                                      
      cash, cash equivalents and restricted cash - september 30
                                                                            
      cash, cash equivalents and restricted cash - june 30
                                                                            
      cash, cash equivalents and restricted cash - march 31
      278,700,000    347,100,000    477,000,000    901,400,000   706,300,000                                                       
      cash flows from operating activities
                                                                            
      (gain) loss on sale of securities
                                                                            
      pension settlement loss
                                                                           
      gain on sale of business
           -56,500,000                                                              
      gain on sale of equity investment
                                                                           
      other current assets and noncurrent assets
                                                                            
      cash flows from investing activities
                                                                            
      proceeds from sale of business
           158,400,000                                                             
      acquisition of business
           -41,000,000                                 -22,200,000 -1,353,600,000                           
      cash flows from financing activities
                                                                            
      payments from inventory financing arrangement
                                                                            
      cash, cash equivalents and restricted cash—beginning of year
                                                                            
      cash, cash equivalents and restricted cash—end of year
                                                                            
      unrealized gain on derivatives
        -38,700,000     -46,100,000 5,900,000      -38,400,000 -7,100,000  -40,200,000 -4,700,000 51,900,000  -10,600,000 1,600,000 -46,900,000 44,600,000 -12,000,000 12,100,000 14,200,000 14,000,000                    -41,300,000 13,200,000 -8,700,000   -17,000,000 -22,300,000 15,700,000   -38,400,000            
      unrealized loss on derivatives
          32,600,000                                                17,300,000       19,000,000           
      accretion expense for leases
             5,700,000 5,000,000 4,800,000 4,600,000 3,300,000 3,200,000 3,100,000 3,400,000 3,800,000 5,200,000 5,400,000                                                     
      mine closure costs
                                                                           
      loss on sale of securities
                                                                            
      write down of inventory to net realizable value
                                                                            
      equity in net (earnings) loss of nonconsolidated companies, net of dividends
               -52,800,000 -72,100,000 -35,900,000 -30,700,000                                                          
      purchases of held-to-maturity securities
                   -2,400,000 -800,000 -5,400,000 -700,000 -900,000 -1,500,000 -13,000,000                                               
      proceeds from sale of held-to-maturity securities
                  1,700,000 800,000 900,000 800,000 2,300,000                                               
      equity in net income of nonconsolidated companies, net of dividends
                   1,300,000 7,600,000 7,500,000 14,900,000 32,400,000 29,800,000 20,000,000 25,200,000 24,600,000 11,200,000 3,600,000    3,300,000            1,400,000  4,100,000                             
      net proceeds from settlement of interest rate swaps
                                                                          
      proceeds from long-term debt
                                                                            
      collection of transferred receivables
                     86,600,000                                                       
      amortization of acquired inventory
                          -200,000 -4,100,000 -1,200,000 -1,800,000 -1,500,000 -15,800,000 -30,100,000             9,300,000 4,200,000                             
      impairment of goodwill
                                                                            
      colonsay and plant city closure costs
                                                                            
      gain on disposal of fixed assets
                                                                            
      changes in assets and liabilities, net of acquisitions:
                                                                            
      proceeds from sale of assets
                                                                            
      acquisition, net of cash acquired
                              9,300,000 -994,600,000                                           
      impairment, restructuring and other incomes
                                                                            
      purchase of assets
                                                                           
      investments in nonconsolidated companies
                                     -144,000,000   -102,100,000 -122,000,000 -3,000,000 -2,600,000 -2,400,000 -143,800,000 -5,800,000 -134,500,000                         -300,000 
      investments in consolidated affiliate
                              2,100,000 -4,900,000 1,300,000 -1,800,000 -8,800,000 -13,900,000 -25,000,000                                       
      payment of financing costs
                                                                            
      plant city closure costs
                           -15,600,000                                                 
      loss on sale of fixed assets
                           4,900,000                                                 
      changes in assets and liabilities, excluding effects of acquisition:
                                                                            
      proceeds from sale of fixed assets
                                 1,200,000                                           
      loss on write-down of long-lived asset
                                      -3,500,000                                     
      cash, cash equivalents and restricted cash—beginning of period
                                                                            
      cash, cash equivalents and restricted cash—end of period
                                                                            
      equity in net income (earnings) of nonconsolidated companies, net of dividends
                               9,400,000    -9,700,000   2,500,000           3,300,000             8,500,000              
      (gain) loss on sale of fixed assets
                                 400,000                                           
      (gain) loss on disposal of fixed assets
                                                                            
      proceeds from adjustment to acquisition of business
                                          47,900,000                               
      return of investment from nonconsolidated companies
                                                                           
      net cash (used in) investing activities
                                                                            
      net change in cash and cash equivalents
                                      19,600,000 -405,800,000 1,600,000 -218,600,000 -8,600,000 -925,000,000 -307,500,000 142,800,000 -596,000,000 603,600,000 -123,700,000 -2,802,400,000 -576,900,000 374,400,000 -98,000,000 -174,100,000 -216,200,000 609,100,000 -425,700,000 -410,400,000 131,600,000 -307,300,000 1,296,700,000 -160,300,000 -356,300,000 49,400,000 -104,500,000 -282,600,000 621,900,000 229,000,000 492,000,000 3,000,000 218,600,000 191,300,000 53,600,000 41,500,000 -43,700,000 -11,400,000 
      cash and cash equivalents—beginning of period
                                                   3,811,000,000 3,906,400,000 2,523,000,000 2,703,200,000 1,960,700,000 420,600,000 173,300,000 245,000,000  
      cash and cash equivalents—end of period
                                                   374,400,000 -98,000,000 -174,100,000 3,594,800,000 609,100,000 -425,700,000 -410,400,000 4,038,000,000 -307,300,000 1,296,700,000 2,362,700,000 -356,300,000 49,400,000 2,598,700,000 -282,600,000 621,900,000 2,189,700,000 492,000,000 3,000,000 639,200,000 191,300,000 53,600,000 214,800,000 201,300,000 -11,400,000 
      proceeds from settlement of swaps
                                        4,200,000                                   
      proceeds from stock option exercises
                                       1,200,000 1,800,000 800,000  1,100,000 1,300,000 2,900,000  1,000,000 1,100,000 200,000 500,000                          
      change in value of share repurchase agreement
                                              -5,300,000 5,500,000 60,000,000                           
      carlsbad restructuring expense
                                              58,400,000                              
      restricted cash
                                      229,000,000            4,500,000 -4,300,000 4,900,000 3,000,000 1,200,000 2,600,000 -1,500,000 -11,700,000          -200,000      
      proceeds from sale of businesses
                                                                    400,000 -300,000 7,800,000      
      acquisition of businesses
                                                                            
      net cash (used in) financing activities
                                                                            
      investments in affiliate
                                       -40,000,000 -51,500,000 -38,500,000                                   
      equity in net earnings of nonconsolidated companies, net of dividends
                                        19,800,000 7,600,000  2,700,000       7,000,000  600,000 -4,700,000 9,300,000       -3,800,000   -2,500,000 -6,000,000 -29,100,000 -27,700,000       -10,200,000  
      deferred income taxes
                                          102,600,000 -55,700,000 32,000,000 -31,500,000 -56,400,000 -5,400,000 -33,100,000 -58,900,000  224,100,000 600,000 -55,100,000 30,400,000 164,000,000 -47,600,000 76,800,000 52,600,000 52,200,000 36,500,000 -30,400,000 1,100,000 23,300,000 11,600,000 -46,700,000 149,300,000 15,300,000       57,600,000  
      (gain) loss on assets sold and to be sold
                                              9,700,000                              
      accounts payable
                                          -75,800,000 249,800,000 125,800,000 2,000,000 4,900,000 6,500,000 179,000,000 86,800,000 -104,100,000 -3,200,000 -114,300,000 45,000,000 -28,000,000 93,700,000 -3,400,000 -114,500,000 -34,200,000 95,300,000 26,500,000 -27,500,000 -26,300,000 34,800,000 77,000,000 -444,600,000 -476,200,000 273,900,000       -800,000 -20,000,000 
      accrued liabilities
                                                               -121,500,000 -299,800,000 -69,700,000 -357,700,000 138,200,000         
      realized loss on interest rate swap
                                                                            
      repurchase of stock
                                                                            
      (gain) on assets sold and to be sold
                                                                            
      accrued liabilities and income taxes
                                           -28,200,000 -62,600,000 82,000,000  -104,000,000 94,600,000 77,200,000 -221,000,000  -11,700,000 -150,300,000 -79,100,000  29,900,000 -115,100,000 -130,000,000 49,700,000 -68,000,000 116,200,000               
      supplemental disclosure of cash flow information:
                                                                            
      cash paid during the period for:
                                                                            
      interest
                                            58,900,000 4,400,000  1,300,000       3,900,000    13,900,000 34,400,000 -11,200,000 32,900,000 33,800,000 -6,800,000 39,600,000 43,600,000 500,000 47,400,000 55,600,000 16,000,000 63,400,000 85,300,000 10,100,000 96,100,000   
      income taxes
                                            91,600,000 46,400,000  -21,600,000 36,000,000 24,300,000   80,000,000 103,200,000 82,300,000  119,900,000 185,400,000 150,100,000 128,000,000 229,300,000 77,200,000 118,100,000 103,500,000 271,000,000 155,400,000 567,800,000 192,700,000 104,800,000 48,500,000 48,500,000 19,900,000 19,400,000 18,000,000   
      payment of tender premium on debt
                                                              -200,000 -5,500,000   -200,000         
      contributions by cargill
                                                                            
      cash and cash equivalents—december 31
                                                5,293,100,000                           
      cash and cash equivalents—june 30
                                                  3,915,500,000                          
      cash and cash equivalents—march 31
                                                 2,490,700,000                           
      loss on write-down of assets
                                                  122,800,000                          
      unrealized (gain) on derivatives
                                                  -40,700,000                          
      dividends
                                                  -106,800,000  -106,700,000 -106,700,000 -106,600,000                      
      cash and cash equivalents—september 30
                                                  3,338,600,000                          
      excess tax benefits related to share-based compensation
                                                                            
      proceeds from sale of equity investment
                                                                           
      distributions received from equity investments
                                                                            
      proceeds from stock options exercised
                                                       500,000 200,000 1,100,000 1,200,000 8,000,000 9,200,000 1,500,000 5,800,000 2,800,000 2,200,000 200,000 3,000,000 1,100,000 11,200,000 19,200,000 18,400,000 14,500,000 20,400,000 1,500,000 23,500,000  
      repurchase of class a common stock
                                                                          
      proceeds from stock option exercise
                                                    2,100,000 500,000 1,700,000                      
      net earnings including non-controlling interests
                                                           542,600,000 1,026,800,000 298,900,000 223,500,000 109,000,000 102,500,000            
      adjustments to reconcile net earnings including non-controlling interests to net cash from operating activities:
                                                                            
      equity in loss of nonconsolidated companies, net of dividends
                                                                            
      equity in loss (earnings) of nonconsolidated companies, net of dividends
                                                         200,000 700,000                  
      excess tax benefit related to stock option exercises
                                                           -5,900,000 -5,500,000 -700,000               
      equity in (net earnings) loss of nonconsolidated companies, net of dividends
                                                                            
      stock-based compensation expense
                                                            3,000,000 13,100,000 3,100,000 3,200,000 14,200,000            
      purchase of equity investment
                                                            -385,300,000               
      dividends paid to non-controlling interests
                                                                            
      dividend paid to minority shareholder
                                                             -100,000 -800,000 -100,000 -300,000 -400,000 -1,400,000 -1,600,000 -3,400,000 -100,000      
      balance as of may 31, 2009
                                                             444,500,000 444,500,000            
      net earnings including non-controlling interest
                                                                            
      foreign currency translation adjustment, net of tax of 41.3
                                                                            
      net actuarial loss and prior service cost, net of tax of 34.0 million
                                                                            
      comprehensive income
                                                                            
      stock option exercises
                                                             900,000 600,000            
      amortization of stock based compensation
                                                                            
      dividends for non-controlling interests
                                                                            
      tax benefits related to share based compensation
                                                                            
      balance as of may 31, 2010
                                                             445,400,000               
      foreign currency translation net of tax of 0.3 million
                                                                            
      net actuarial gain and prior service cost, net of tax benefit of 13.2 million
                                                                            
      tax shortfall related to share based compensation
                                                                            
      balance as of august 31, 2010
                                                             445,600,000               
      lower of cost or market write-down
                                                                 28,300,000           
      proceeds from saskferco note receivable
                                                                           
      excess tax benefits related to stock option exercises
                                                              -3,300,000 500,000 -400,000 -2,000,000 -2,800,000         
      balance as of may 31, 2008
                                                              443,900,000            
      adoption of new defined benefit pension and postretirement measurement guidance, net of tax of 0.2
                                                                            
      beginning balance, as adjusted
                                                              443,900,000            
      net earnings
                                                                 58,800,000 959,800,000 1,184,700,000       76,100,000 38,800,000 
      foreign currency translation adjustment, net of tax of 13.3
                                                                            
      net actuarial loss, net of tax of 31.2
                                                                            
      comprehensive income for 2009
                                                                            
      distributions to cargill, inc.
                                                                            
      tax benefits related to stock option exercises
                                                                            
      foreign currency translation adjustment, net of tax of 3.2
                                                                            
      net actuarial loss
                                                                            
      balance as of february 28, 2010
                                                                            
      other current assets
                                                               1,700,000 8,900,000   -55,100,000       -7,300,000 29,600,000 
      foreign currency translation adjustment, net of tax of 3.5
                                                                            
      balance as of november 30, 2009
                                                                            
      adoption of fas 158 measurement date, net of tax of 0.2
                                                                            
      dividends paid
                                                                            
      foreign currency translation adjustment, net of tax of 4.2
                                                                            
      net actuarial loss, net of tax of 0
                                                                            
      comprehensive income for 2010
                                                                            
      balance as of august 31, 2009
                                                                444,900,000            
      adjustments to reconcile net earnings to net cash from operating activities:
                                                                            
      minority interest
                                                                 -700,000 1,600,000 3,800,000       2,200,000 -500,000 
      amortization of out-of-market contracts
                                                                 -3,100,000         -4,500,000  
      amortization of stock-based compensation expense
                                                                 3,600,000 3,800,000 10,100,000         
      gain on sale of equity method investment
                                                                           
      proceeds from sale of equity method investment
                                                                           
      payments of restricted cash
                                                                 3,700,000 -31,100,000 -1,200,000         
      contributions from cargill, incorporated
                                                                    2,200,000        
      basic weighted-average common shares outstanding
                                                                 100,000 200,000 444,100,000         
      common stock issuable upon vesting of restricted stock awards
                                                                 -100,000 -100,000 600,000         
      common stock equivalents
                                                                 -300,000 -500,000 1,800,000         
      diluted weighted-average common shares outstanding
                                                                 -300,000 -400,000 446,500,000         
      earnings per share—basic
                                                                 -2,030,000 -510,000 2,670,000         
      earnings per share—diluted
                                                                 -2,020,000 -500,000 2,650,000         
      restructuring and other charges
                                                                            
      proceeds from sale of investment
                                                                            
      payments for deferred financing costs
                                                                            
      payment for swap termination
                                                                            
      proceeds from note receivable from saskferco products inc.
                                                                            
      payments on debt due to cargill, inc. and affiliates
                                                                            
      effect of exchange rate changes on cash and cash equivalents
                                                                       14,400,000     
      cash acquired in acquisition of imc global inc.
                                                                            
      proceeds from (investment in) note of saskferco products, inc.
                                                                            
      investment in nonconsolidated companies
                                                                            
      payments of short-term and long-term debt
                                                                          -71,700,000  
      proceeds from issuance of short-term and long-term debt
                                                                          14,000,000  
      contributions by cargill, inc.
                                                                            
      changes in short-term and long-term debt due to cargill, inc and affiliates
                                                                            
      increase in debt refinancing and issuance costs
                                                                            
      cumulative effect of a change in accounting principle
                                                                           
      settlement of asset retirement obligations
                                                                          -6,800,000  
      amortization of fair market value adjustment of debt
                                                                          -12,000,000  
      amortization of debt financing fees and stock-based compensation expense
                                                                          2,700,000  
      pension and postretirement obligations funding
                                                                          -8,200,000  
      unrealized gains on derivatives
                                                                          -61,300,000  
      other charges
                                                                          200,000 7,400,000 
      other credits
                                                                          -5,800,000 -26,300,000 
      accrued expenses
                                                                          -24,500,000 -77,800,000 
      other current liabilities
                                                                          7,600,000 15,100,000 
      due to/from cargill, incorporated and affiliates
                                                                          26,300,000 18,800,000 
      proceeds from (investment in) note of saskferco products inc.
                                                                          11,800,000  
      proceeds from the sale of assets
                                                                          500,000 100,000 
      contributions by cargill, incorporated
                                                                            
      changes in short-term and long-term debt due to cargill, incorporated and affiliates
                                                                          -100,000 -29,000,000 
      deferred income taxes, exclusive of acquisition
                                                                            
      increase in equity earnings in nonconsolidated companies, net of dividends
                                                                            
      changes in assets and liabilities, exclusive of acquisition:
                                                                            
      acquisition of imc global inc., net of cash acquired
                                                                           
      investment in note of saskferco products inc.
                                                                           -300,000 
      investments in businesses acquired and minority interests
                                                                            
      changes in short-term debt
                                                                           28,300,000 
      stock options exercised and restricted stock awards
                                                                           16,000,000 
      debt refinancing and issuance costs
                                                                            
      cash and cash equivalents—beginning of year
                                                                           
      non cash investing activities:
                                                                            
      issuance of mosaic common stock, preferred stock and stock options in exchange for imc common stock, preferred stock and stock options
                                                                           
      non cash financing activities:
                                                                            
      contributions from cargill, incorporated to convert short and long-term debt to common stock and capital in excess of par value
                                                                           10,300,000 
      increase in equity in nonconsolidated companies, net of dividends
                                                                            
      increase in restricted cash
                                                                            
      cash dividends paid to cargill, incorporated
                                                                            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.